Apogee Therapeutics is a biotechnology company advancing next-generation antibody therapies for respiratory and inflammatory diseases. Its innovative approach targets conditions like asthma and chronic obstructive pulmonary disease (COPD) by improving drug durability and patient convenience. Patients with moderate to severe respiratory conditions benefit from potentially fewer injections and better symptom control, while healthcare providers gain a more effective treatment option.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends